Hovione Announces Partnership to Produce Ligand’s Captisol; Used in Gilead’s Covid-19 Treatment
Drug Development & Delivery, September 23, 2020
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Drug Development & Delivery, September 23, 2020
Loures, Portugal, June 6, 2016 – Hovione is pleased to announce the opening of its new sales and customer support office in Osaka, Japan.
Chemical Week, 15 February 2006
C&EN, 26 September 2021
We constantly innovate to find better, more efficient ways of doing things.
Manufacturing Chemist, September 23, 2020
Commitment to partnership and joint innovation for cell and gene therapies
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Published in Pharma’s Almanac, February 2016
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016